127 related articles for article (PubMed ID: 17976876)
1. Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine.
Greco R; Michel M; Guetard D; Cervantes-Gonzalez M; Pelucchi N; Wain-Hobson S; Sala F; Sala M
Vaccine; 2007 Nov; 25(49):8228-40. PubMed ID: 17976876
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 derived peptides fused to HBsAg affect its immunogenicity.
Gonzalez MC; Kostrzak A; Guetard D; Pniewski T; Sala M
Virus Res; 2009 Dec; 146(1-2):107-14. PubMed ID: 19766153
[TBL] [Abstract][Full Text] [Related]
3. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.
Michel M; Lone YC; Centlivre M; Roux P; Wain-Hobson S; Sala M
Vaccine; 2007 Feb; 25(10):1901-11. PubMed ID: 17005303
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration.
Guetard D; Greco R; Cervantes Gonzalez M; Celli S; Kostrzak A; Langlade-Demoyen P; Sala F; Wain-Hobson S; Sala M
Vaccine; 2008 Aug; 26(35):4477-85. PubMed ID: 18601967
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR.
Matoba N; Kajiura H; Cherni I; Doran JD; Bomsel M; Fujiyama K; Mor TS
Plant Biotechnol J; 2009 Feb; 7(2):129-45. PubMed ID: 19037902
[TBL] [Abstract][Full Text] [Related]
6. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.
Kohl TO; Hitzeroth II; Christensen ND; Rybicki EP
BMC Biotechnol; 2007 Sep; 7():56. PubMed ID: 17850660
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production.
Obregon P; Chargelegue D; Drake PM; Prada A; Nuttall J; Frigerio L; Ma JK
Plant Biotechnol J; 2006 Mar; 4(2):195-207. PubMed ID: 17177796
[TBL] [Abstract][Full Text] [Related]
8. Feeding of mice with Arabidopsis thaliana expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses.
Lindh I; Kalbina I; Thulin S; Scherbak N; Sävenstrand H; Bråve A; Hinkula J; Strid A; Andersson S
APMIS; 2008 Nov; 116(11):985-94. PubMed ID: 19132995
[TBL] [Abstract][Full Text] [Related]
9. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.
D'Aoust MA; Lavoie PO; Couture MM; Trépanier S; Guay JM; Dargis M; Mongrand S; Landry N; Ward BJ; Vézina LP
Plant Biotechnol J; 2008 Dec; 6(9):930-40. PubMed ID: 19076615
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
[TBL] [Abstract][Full Text] [Related]
11. Tobacco mosaic virus 126-kDa protein increases the susceptibility of Nicotiana tabacum to other viruses and its dosage affects virus-induced gene silencing.
Harries PA; Palanichelvam K; Bhat S; Nelson RS
Mol Plant Microbe Interact; 2008 Dec; 21(12):1539-48. PubMed ID: 18986250
[TBL] [Abstract][Full Text] [Related]
12. Phenotypes and functional effects caused by various viral RNA silencing suppressors in transgenic Nicotiana benthamiana and N. tabacum.
Siddiqui SA; Sarmiento C; Truve E; Lehto H; Lehto K
Mol Plant Microbe Interact; 2008 Feb; 21(2):178-87. PubMed ID: 18184062
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants.
Floss DM; Sack M; Stadlmann J; Rademacher T; Scheller J; Stöger E; Fischer R; Conrad U
Plant Biotechnol J; 2008 May; 6(4):379-91. PubMed ID: 18312505
[TBL] [Abstract][Full Text] [Related]
14. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
Yang OO
AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558
[No Abstract] [Full Text] [Related]
15. Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles.
Halsey RJ; Tanzer FL; Meyers A; Pillay S; Lynch A; Shephard E; Williamson AL; Rybicki EP
Virus Res; 2008 May; 133(2):259-68. PubMed ID: 18329748
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
[TBL] [Abstract][Full Text] [Related]
17. The use of viral vectors to produce hepatitis B virus core particles in plants.
Mechtcheriakova IA; Eldarov MA; Nicholson L; Shanks M; Skryabin KG; Lomonossoff GP
J Virol Methods; 2006 Jan; 131(1):10-5. PubMed ID: 16112207
[TBL] [Abstract][Full Text] [Related]
18. Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system.
Pillay S; Meyers A; Williamson AL; Rybicki EP
Biotechnol Prog; 2009; 25(4):1153-60. PubMed ID: 19572400
[TBL] [Abstract][Full Text] [Related]
19. Production of hepatitis B surface antigen in recombinant plant systems: an update.
Kumar GB; Ganapathi TR; Bapat VA
Biotechnol Prog; 2007; 23(3):532-9. PubMed ID: 17348684
[TBL] [Abstract][Full Text] [Related]
20. Assessment of CaMV-mediated gene silencing and integration of CaMV into GM plants with a 35S RNA promoter.
Squires J; Stephens J; Shoelz JE; Palukaitis P
Environ Biosafety Res; 2007; 6(4):259-70. PubMed ID: 18289501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
